Eli Lilly Says Weight Loss Pill On Track for 2Q Launch in US
Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Federal Drug...
By Bloomberg Markets · Bloomberg Markets
Eli Lilly Chief Financial Officer Lucas Montarce says their weight loss pill is on track to launch in the US in the second quarter, pending approval by the Federal Drug Administration. Montarce says they "feel good about the progress." He speaks to Katie Greifeld. (Source: Bloomberg)